Cannabis Bioscience International Holdings, Inc.
CBIH · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | -0.00 |
| FCF Yield | -5,126.54% | -7,743.75% | -22,783.71% | -26,441.62% |
| EV / EBITDA | -1.23 | -0.89 | -0.43 | -0.43 |
| Quality | ||||
| ROIC | 56.68% | 75.71% | 470.88% | -3,435.97% |
| Gross Margin | 86.76% | 81.68% | 70.50% | 78.25% |
| Cash Conversion Ratio | 0.60 | 0.74 | 0.88 | 0.97 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.47% | 5.00% | -25.35% | -28.18% |
| Free Cash Flow Growth | 31.24% | 47.50% | -6.71% | -68.54% |
| Safety | ||||
| Net Debt / EBITDA | -1.21 | -0.88 | -0.42 | -0.43 |
| Interest Coverage | -2.34 | -2.94 | -10.81 | -17.40 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -894.50 | -1,540.06 | -422.56 | -502.49 |